|
ARHGAP11B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.791200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.424000E-01 |
| Normal-vs-Stage2 |
1.263360E-01 |
| Normal-vs-Stage3 |
2.011200E-01 |
| Normal-vs-Stage4 |
7.124000E-01 |
| Stage1-vs-Stage2 |
2.998200E-01 |
| Stage1-vs-Stage3 |
4.585800E-01 |
| Stage1-vs-Stage4 |
6.523200E-01 |
| Stage2-vs-Stage3 |
6.462600E-01 |
| Stage2-vs-Stage4 |
2.802200E-01 |
| Stage3-vs-Stage4 |
4.201200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.451600E-01 |
| Normal-vs-AfricanAmerican |
5.697400E-01 |
| Normal-vs-Asian |
3.867600E-01 |
| Caucasian-vs-AfricanAmerican |
8.473000E-01 |
| Caucasian-vs-Asian |
9.369600E-01 |
| AfricanAmerican-vs-Asian |
8.123200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.733800E-01 |
| Normal-vs-Female |
3.010200E-01 |
| Male-vs-Female |
7.785200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.616600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.014300E-02 |
| Normal-vs-Age(61-80Yrs) |
3.312400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.483600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.706310E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.598200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.152200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.650600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.452990E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.100000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.748400E-01 |
| Classical-VS-Follicular |
4.591500E-02 |
| Classical-VS-Other |
2.643700E-03 |
| Classical-VS-Normal |
5.180000E-01 |
| Tall-VS-Follicular |
5.724800E-01 |
| Tall-VS-Other |
8.081600E-02 |
| Tall-VS-Normal |
2.787200E-01 |
| Follicular-VS-Other |
3.517600E-02 |
| Follicular-VS-Normal |
9.248200E-02 |
| Other-VS-Normal |
2.761600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.778170E-01 |
| Normal-vs-N1 |
2.669000E-01 |
| N0-vs-N1 |
9.019400E-01 |
|
|
